ReviewOncoTargets and therapy2017

Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia.

Henriette Huber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.